Hepatitis C virus (HCV) infection significantly impacted patients with hereditary bleeding disorders due to non-inactivated clotting factors in the 1970s. This review covers HCV prevalence, genotypes, natural history, disease progression, and modern treatment advancements in hemophiliacs.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Discussion:
Key Insights:
Outlook: